| Literature DB >> 34762111 |
Lindsay Horton1, Jonathan Rhodes2, David K Menon3, Andrew I R Maas4, Lindsay Wilson1.
Abstract
Importance: An interview is considered the gold standard method of assessing global functional outcomes in clinical trials among patients with acute traumatic brain injury (TBI). However, several multicenter clinical trials have used questionnaires completed by a patient or caregiver to assess the primary end point. Objective: To examine agreement between interview and questionnaire formats for assessing TBI outcomes and to consider whether an interview has advantages. Design, Setting, and Participants: This cohort study used data from patients enrolled in the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) project from December 2014 to December 2017. Data were analyzed from December 2020 to April 2021. Included patients were aged 16 years or older with TBI and a clinical indication for computed tomography imaging. Outcome assessments were completed using both an interview and a questionnaire at follow-up 3 and 6 months after injury. Exposures: Traumatic brain injury of all severities. Main Outcomes and Measures: Ratings on the Glasgow Outcome Scale-Extended (GOSE) administered as a structured interview rated by an investigator and as a questionnaire completed by patients or caregivers and scored centrally were compared, and the strength of agreement was evaluated using weighted κ statistics. Secondary outcomes included comparison of different sections of the GOSE assessments and the association of GOSE ratings with baseline factors and patient-reported mental health, health-related quality of life, and TBI symptoms.Entities:
Mesh:
Year: 2021 PMID: 34762111 PMCID: PMC8586906 DOI: 10.1001/jamanetworkopen.2021.34121
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Demographic and Clinical Characteristics of Respondents
| Characteristic | Respondents, No. (%) | ||
|---|---|---|---|
| 3-mo Follow-up (n = 994) | 6-mo Follow-up (n = 628) | Total eligible (N = 3691) | |
| Age, median (IQR), y | 53 (33-66) | 51 (31-64) | 49 (31-64) |
| Sex | |||
| Male | 654 (65.8) | 409 (65.1) | 2487 (67.4) |
| Female | 340 (34.2) | 219 (34.9) | 1204 (32.6) |
| Race and ethnicity | |||
| Asian | 12 (1.2) | 7 (1.1) | 56 (1.6) |
| Black | 12 (1.2) | 5 (0.8) | 57 (1.6) |
| White | 946 (97.5) | 605 (98.1) | 3419 (96.8) |
| Missing or unknown | 24 (2.4) | 11 (1.8) | 159 (4.3) |
| Educational level | |||
| Primary | 90 (10.8) | 65 (13.1) | 459 (14.8) |
| Secondary | 275 (32.9) | 183(36.9) | 1108 (35.7) |
| Training | 202 (24.2) | 103 (20.8) | 646 (20.8) |
| College | 268 (32.1) | 145 (29.2) | 888 (28.6) |
| Missing | 159 (16.0) | 132 (21.0) | 590 (16.0) |
| Employment status before injury | |||
| Working full or part time | 476 (52.0) | 310 (55.3) | 1804 (53.7) |
| Not working | 71 (7.8) | 52 (9.3) | 317 (9.4) |
| Retired | 257 (28.1) | 134 (23.9) | 828 (24.7) |
| Student or homemaker | 112 (12.2) | 65 (11.6) | 409 (12.2) |
| Missing | 78 (7.8) | 67 (10.7) | 333 (9.0) |
| Marital status | |||
| Partnered | 524 (55.8) | 303 (52.6) | 1751 (51.5) |
| Previously partnered | 132 (14.1) | 77 (13.4) | 520 (15.3) |
| Single or other | 283 (30.1) | 196 (34.0) | 1126 (33.1) |
| Unknown | 55 (5.5) | 52 (8.3) | 294 (8.0) |
| ASA preinjury physical health | |||
| Healthy patient | 592 (60.3) | 367 (59.8) | 2126 (58.9) |
| Mild systemic disease | 312 (31.8) | 196 (31.9) | 1156 (32.0) |
| Severe systemic disease | 77 (7.8) | 51 (8.3) | 325 (9.0) |
| Missing | 13 (1.3) | 14 (2.2) | 84 (2.3) |
| Cause of injury | |||
| Road traffic accident | 407 (41.6) | 256 (42.0) | 1411 (39.2) |
| Fall | 423 (43.3) | 251 (41.2) | 1617 (45.0) |
| Violence or assault | 67 (6.9) | 43 (7.1) | 208 (5.8) |
| Other | 81 (8.3) | 59 (9.7) | 361 (10.0) |
| Missing or unknown | 16 (1.6) | 19 (3.0) | 94 (2.5) |
| Clinical care pathway | |||
| Emergency department | 179 (18.0) | 129 (20.5) | 774 (21.0) |
| Admitted to hospital | 376 (37.8) | 181 (28.8) | 1324 (35.9) |
| Intensive care unit | 439 (44.2) | 318 (50.6) | 1593 (43.2) |
| GCS score at baseline | |||
| 13-15 | 683 (72.0) | 392 (66.3) | 2624 (73.5) |
| 9-12 | 93 (9.8) | 65 (11.0) | 285 (8.0) |
| 3-8 | 172 (18.1) | 134 (22.7) | 659 (18.5) |
| Missing | 46 (4.6) | 37 (5.9) | 123 (3.3) |
| CT imaging abnormal finding | |||
| Present | 525 (57.1) | 338 (58.9) | 1911 (56.7) |
| Absent | 394 (42.9) | 236 (41.1) | 1462 (43.3) |
| Missing | 75 (7.5) | 54 (8.6) | 318 (8.6) |
| Pupillary reactivity | |||
| Both reactive | 874 (94.8) | 538 (92.9) | 3238 (93.1) |
| 1 Pupil unreactive | 25 (2.7) | 20 (3.5) | 118 (3.4) |
| 2 Pupils unreactive | 23 (2.5) | 21 (3.6) | 121 (3.5) |
| Missing | 72 (7.2) | 49 (7.8) | 214 (5.8) |
| Total ISS, median (IQR) | 16 (9-26) | 16 (8-29) | 16 (9-26) |
| Head and neck AIS score | |||
| No injury or minor injury | 167 (16.8) | 112 (17.8) | 655 (17.7) |
| Moderate injury | 133 (13.4) | 86 (13.7) | 521 (14.1) |
| Serious injury | 321 (32.3) | 146 (23.2) | 1128 (30.6) |
| Severe injury | 165 (16.6) | 119 (18.9) | 637 (17.3) |
| Critical injury | 206 (20.9) | 165 (26.3) | 750 (20.3) |
| Major extracranial injury | |||
| No injury or mild injury | 643 (64.7) | 424 (67.5) | 2435 (66.0) |
| Severe injury | 351 (35.3) | 204 (32.5) | 1256 (34.0) |
Abbreviations: AIS, Abbreviated Injury Scale; ASA, American Society of Anesthesiologists; CT, computed tomography; GCS, Glasgow Coma Scale; ISS, Injury Severity Score.
Percentages for observed values exclude missing data from the calculations.
Combined AIS score for head, neck, and cervical regions.
Any non–head and neck AIS score of 3 or higher (serious injury).
Assessment Characteristics and Respondents
| Characteristic | Respondents, No. (%) | |
|---|---|---|
| 3-mo Follow-up (n = 994) | 6-mo Follow-up (n = 628) | |
| Interval between assessments, d | ||
| Same day | 547 (55.0) | 483 (76.9) |
| 1-7 | 217 (21.8) | 88 (14.0) |
| 8-14 | 145 (14.6) | 34 (5.4) |
| 15-21 | 85 (8.6) | 23 (3.7) |
| Order of assessments | ||
| Interview ≥1 d before questionnaire | 297 (29.9) | 68 (10.8) |
| Interview and questionnaire on same day | 547 (55.0) | 483 (76.9) |
| Interview ≥1 d after questionnaire | 150 (15.2) | 77 (12.3) |
| GOSE interview respondent | ||
| Patient alone | 766 (78.2) | 494 (81.3) |
| Relative, friend, or caregiver alone | 134 (13.7) | 61 (10.0) |
| Patient plus relative, friend, or caregiver | 80 (8.2) | 53 (8.7) |
| Missing | 14 (1.4) | 20 (3.2) |
| GOSE questionnaire respondent | ||
| Patient alone | 738 (74.4) | 504 (80.4) |
| Relative, friend, or caregiver alone | 97 (9.8) | 59 (9.4) |
| Patient plus relative, friend, or caregiver | 157 (15.8) | 64 (10.2) |
| Missing | 2 (0.2) | 1 (0.2) |
Abbreviation: GOSE, Glasgow Outcome Scale–Extended.
Agreement Between Individual Sections of the Glasgow Outcome Scale–Extended Interview and Questionnaire at the 3-Month and 6-Month Follow-up
| Section | Responses, No. | Exact agreement, No. (%) | κ (95% CI) |
|---|---|---|---|
| 3-mo Follow-up | |||
| Assistance at home | 979 | 891 (91.0) | 0.70 (0.64-0.76) |
| Shopping | 979 | 927 (94.7) | 0.79 (0.75-0.85) |
| Travel | 979 | 923 (94.3) | 0.79 (0.74-0.85) |
| Work | 964 | 847 (87.9) | 0.70 (0.65-0.75) |
| Social and leisure | 977 | 788 (80.7) | 0.60 (0.55-0.65) |
| Relationships | 973 | 866 (89.0) | 0.50 (0.42-0.58) |
| Symptoms | 978 | 702 (71.8) | 0.45 (0.40-0.50) |
| 6-mo Follow-up | |||
| Assistance at home | 603 | 561 (93.0) | 0.73 (0.66-0.81) |
| Shopping | 602 | 568 (94.4) | 0.74 (0.65-0.82) |
| Travel | 603 | 571 (94.7) | 0.76 (0.68-0.84) |
| Work | 600 | 541 (90.2) | 0.74 (0.67-0.80) |
| Social and leisure | 602 | 498 (82.7) | 0.61 (0.55-0.68) |
| Relationships | 603 | 525 (87.1) | 0.51 (0.41-0.60) |
| Symptoms | 601 | 425 (70.7) | 0.41 (0.34-0.48) |
Figure. Problems and Limitations After Traumatic Brain Injury as Recorded on Subsections of the Glasgow Outcome Scale–Extended Questionnaire and Interview at 3-Month and 6-Month Follow-up
Whiskers indicate 95% CIs.
aDifference significant at P < .01.
Spearman Correlations Between GOSE Ratings, Baseline Factors, and 6-Month Outcomes and Differences Between Correlations
| Factor | Data points, No. | Spearman correlation, ρ | Difference (95% CI) | ||
|---|---|---|---|---|---|
| GOSE interview | GOSE questionnaire | ||||
| Baseline factor | |||||
| Age | 628 | −0.12 | −0.06 | −0.06 (−0.13 to −0.01) | .03 |
| GCS score | 591 | 0.42 | 0.44 | −0.02 (−0.07 to 0.03) | .47 |
| Pupillary reactivity | 579 | −0.18 | −0.16 | −0.02 (−0.08 to 0.04) | .54 |
| Total ISS | 618 | −0.43 | −0.47 | 0.04 (−0.01 to 0.10) | .11 |
| Head and neck AIS score | 628 | −0.47 | −0.49 | 0.02 (−0.03 to 0.06) | .54 |
| Major extracranial injury | 628 | −0.24 | −0.30 | 0.06 (0.01 to 0.11) | .01 |
| 6-mo Outcome | |||||
| SF-36v2 | |||||
| Physical functioning | 497 | 0.53 | 0.50 | 0.03 (−0.03 to 0.10) | .28 |
| Role-physical | 495 | 0.63 | 0.65 | −0.02 (−0.08 to 0.03) | .43 |
| Pain | 495 | 0.33 | 0.31 | 0.02 (−0.04 to 0.08) | .58 |
| General health | 497 | 0.41 | 0.36 | 0.05 (−0.01 to 0.10) | .14 |
| Social functioning | 495 | 0.49 | 0.52 | −0.03 (−0.08 to 0.03) | .35 |
| Role-emotional | 495 | 0.44 | 0.44 | <0.01 (−0.06 to 0.07) | .96 |
| Energy and fatigue | 492 | 0.43 | 0.42 | 0.01 (−0.04 to 0.07) | .58 |
| Mental health | 492 | 0.34 | 0.32 | 0.02 (−0.04 to 0.07) | .51 |
| MCS score | 491 | 0.36 | 0.36 | <0.01 (−0.06 to 0.06) | .91 |
| PCS score | 491 | 0.56 | 0.55 | 0.01 (−0.05 to 0.07) | .71 |
| QOLIBRI | |||||
| Cognition | 483 | 0.44 | 0.40 | 0.04 (−0.02 to 0.10) | .17 |
| Self | 483 | 0.39 | 0.37 | 0.02 (−0.03 to 0.08) | .43 |
| Daily life and autonomy | 483 | 0.58 | 0.59 | −0.01 (−0.06 to 0.05) | .91 |
| Social relationships | 483 | 0.30 | 0.26 | 0.04 (−0.03 to 0.09) | .28 |
| Emotions | 484 | 0.28 | 0.29 | −0.01 (−0.07 to 0.05) | .77 |
| Physical problems | 483 | 0.51 | 0.53 | −0.02 (−0.08 to 0.03) | .38 |
| Total | 483 | 0.53 | 0.52 | 0.01 (−0.04 to 0.07) | .62 |
| PHQ-9 | 493 | −0.48 | −0.48 | <0.01 (−0.05 to 0.06) | .96 |
| GAD-7 | 493 | −0.35 | −0.35 | <0.01 (–0.06 to 0.06) | .97 |
| RPQ | 375 | −0.54 | −0.53 | −0.01 (−0.08 to 0.07) | .83 |
Abbreviations: AIS, Abbreviated Injury Scale; GAD-7, Generalized Anxiety Disorder–7; GCS, Glasgow Coma Scale; GOSE, Glasgow Outcome Scale–Extended; ISS, Injury Severity Score; MCS, Mental Component Summary; PCS, Physical Component Summary; PHQ-9, Patient Health Questionnaire–9 depression scale; QOLIBRI, Quality of Life After Brain Injury; RPQ, Rivermead Post-Concussion Symptoms Questionnaire; SF-36v2, 36-Item Short Form Health Survey, version 2.
The 95% CIs and probabilities were obtained from a percentile bootstrap method.
Correlations were significant at 2-tailed P < .01 except for the correlation of age with GOSE questionnaire at baseline.